These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Why HIV drug resistance matters: an overview. Learned J Posit Aware; 2005; 16(5):26-30. PubMed ID: 16220604 [No Abstract] [Full Text] [Related]
6. [HIV infection. Virus resistance: development and prevention]. Link R; Miller V; Fätkenheuer G; Manegold C; Harrer T Med Monatsschr Pharm; 1999 Mar; 22(3):86-8. PubMed ID: 10223868 [No Abstract] [Full Text] [Related]
7. HIV suppression and risk of drug resistance mutations. Phillips AN; Loveday C; Johnson MA AIDS; 1998 Oct; 12(14):1930. PubMed ID: 9792396 [No Abstract] [Full Text] [Related]
8. Editorial: HIV and Antiretroviral Drugs: Current Status and New Challenges. Nikolopoulos G; Bonovas S Curr Pharm Des; 2017; 23(18):2551. PubMed ID: 28425865 [No Abstract] [Full Text] [Related]
9. [German-Austrian guidelines for antiretroviral therapy of HIV infection. (July, 2002, update)]. Brockmeyer NH; ; Dtsch Med Wochenschr; 2003 May; 128 Suppl 1():S7-18. PubMed ID: 12736863 [No Abstract] [Full Text] [Related]
10. Companies aim at new HIV targets. Brower V Nat Biotechnol; 1996 Sep; 14(9):1079. PubMed ID: 9669875 [No Abstract] [Full Text] [Related]
11. Targeting TNF-Alpha in HIV-1 Infection. Kumar A; Coquard L; Herbein G Curr Drug Targets; 2016; 17(1):15-22. PubMed ID: 26073859 [TBL] [Abstract][Full Text] [Related]
12. Infectious disease. HIV prevention and cure insights come from failure and success. Cohen J Science; 2012 Mar; 335(6074):1291. PubMed ID: 22422953 [No Abstract] [Full Text] [Related]
13. Accrued HIV evidence turns treatment dogma on its head. Check E Nature; 2003 Aug; 424(6951):866. PubMed ID: 12931150 [No Abstract] [Full Text] [Related]
14. [T-20: a fusion inhibitor]. Iafolla M Sidahora; 2002; (3):20-2. PubMed ID: 12703471 [No Abstract] [Full Text] [Related]
15. What's new in HIV. Morris-Jones S; Nelson MR J Infect; 1999 Mar; 38(2):i-ii. PubMed ID: 10342641 [No Abstract] [Full Text] [Related]
16. [HIV: less resistance due to combined treatment]. Dtsch Med Wochenschr; 1996 Dec; 121(49):A47-8. PubMed ID: 8998914 [No Abstract] [Full Text] [Related]
17. How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians. Mascolini M; Wensing AM; Boucher CA IAPAC Mon; 2001 Mar; 7(3):85-90. PubMed ID: 11697306 [No Abstract] [Full Text] [Related]
18. Evidence of Noncompetent HIV after Ex Vivo Purging Among ART-Suppressed Individuals. Samer S; Namiyama G; Oshiro T; Arif MS; Cardoso da Silva W; Sucupira MCA; Janini LM; Diaz RS AIDS Res Hum Retroviruses; 2017 Oct; 33(10):993-994. PubMed ID: 28632400 [No Abstract] [Full Text] [Related]
19. [Biological basis for generating resistance to antiretroviral drugs]. Alcamí J; Delgado R; Menéndez-Arias L Enferm Infecc Microbiol Clin; 2001 Feb; 19(Monografico):3-13. PubMed ID: 11428056 [No Abstract] [Full Text] [Related]
20. Resistance and cross-resistance with saquinavir and other HIV protease inhibitors: theory and practice. Roberts NA; Craig JC; Sheldon J AIDS; 1998 Mar; 12(5):453-60. PubMed ID: 9543442 [No Abstract] [Full Text] [Related] [Next] [New Search]